Monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

Details for Australian Patent Application No. 2009279804 (hide)

Owner Bayer HealthCare LLC

Inventors Wang, Zhuozhi; Murphy, John E.; Pan, Junliang; Jiang, Haiyan; Liu, Bing

Agent Davies Collison Cave

Pub. Number AU-A-2009279804

PCT Pub. Number WO2010/017196

Priority 61/085,980 04.08.08 US

Filing date 4 August 2009

Wipo publication date 11 February 2010

International Classifications

C07K 16/36 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/017196 Priority application(s): WO2010/017196

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279806-FGFR extracellular domain acidic region muteins

2009279803-Pre-execution credit control